6 Patents
- US125024392025Activatable Antibodies That Bind Epidermal Growth Factor Receptor and Methods of Use Thereof
Cytomx Therapeutics, Inc.
0 cites - US124983672025Methods of Qualitatively And/or Quantitatively Analyzing Properties of Activatable Antibodies and Uses Thereof
Cytomx Therapeutics, Inc.
0 cites - US121395432024Method of Using an Anti-epidermal Growth Factor Receptor (EGFR) Activatable Antibody to Detect the Presence or Absence of a Cleaving Agent and EGFR
Cytomx Therapeutics, Inc.
0 cites - US119925282024Compositions and Methods for Conjugating Activatable Antibodies
CYTOMX THERAPEUTICS, Inc.
0 cites - US118903542024Activatable Antibodies That Bind Epidermal Growth Factor Receptor and Methods Thereof
CYTOMX THERAPEUTICS, Inc.
0 cites - US117534662023Anti-cd166 Antibodies, Activatable Anti-cd166 Antibodies, and Methods of Use Thereof
Cytomx Therapeutics, Inc.
0 cites